Review of poliovirus modeling performed from 2000 to 2019 to support global polio eradication
- PMID: 32741232
- PMCID: PMC7497282
- DOI: 10.1080/14760584.2020.1791093
Review of poliovirus modeling performed from 2000 to 2019 to support global polio eradication
Abstract
Introduction: Over the last 20 years (2000-2019) the partners of the Global Polio Eradication Initiative (GPEI) invested in the development and application of mathematical models of poliovirus transmission as well as economics, policy, and risk analyses of polio endgame risk management options, including policies related to poliovirus vaccine use during the polio endgame.
Areas covered: This review provides a historical record of the polio studies published by the three modeling groups that primarily performed the bulk of this work. This review also systematically evaluates the polio transmission and health economic modeling papers published in English in peer-reviewed journals from 2000 to 2019, highlights differences in approaches and methods, shows the geographic coverage of the transmission modeling performed, identified common themes, and discusses instances of similar or conflicting insights or recommendations.
Expert opinion: Polio modeling performed during the last 20 years substantially impacted polio vaccine choices, immunization policies, and the polio eradication pathway. As the polio endgame continues, national preferences for polio vaccine formulations and immunization strategies will likely continue to change. Future modeling will likely provide important insights about their cost-effectiveness and their relative benefits with respect to controlling polio and potentially achieving and maintaining eradication.
Keywords: Poliovirus; eradication; modeling.
Figures
Similar articles
-
Review of Poliovirus Transmission and Economic Modeling to Support Global Polio Eradication: 2020-2024.Pathogens. 2024 May 22;13(6):435. doi: 10.3390/pathogens13060435. Pathogens. 2024. PMID: 38921733 Free PMC article. Review.
-
Reflections on Modeling Poliovirus Transmission and the Polio Eradication Endgame.Risk Anal. 2021 Feb;41(2):229-247. doi: 10.1111/risa.13484. Epub 2020 Apr 27. Risk Anal. 2021. PMID: 32339327 Free PMC article. Review.
-
Evolution of global polio eradication strategies: targets, vaccines, and supplemental immunization activities (SIAs).Expert Rev Vaccines. 2024 Jan-Dec;23(1):597-613. doi: 10.1080/14760584.2024.2361060. Epub 2024 Jun 7. Expert Rev Vaccines. 2024. PMID: 38813792 Review.
-
Modeling and Managing Poliovirus Risks: We are Where we are….Risk Anal. 2021 Feb;41(2):223-228. doi: 10.1111/risa.13668. Risk Anal. 2021. PMID: 33590520 Free PMC article.
-
Health and Economic Outcomes Associated with Polio Vaccine Policy Options: 2019-2029.Risk Anal. 2021 Feb;41(2):364-375. doi: 10.1111/risa.13664. Risk Anal. 2021. PMID: 33590519 Free PMC article.
Cited by
-
Increasing Population Immunity Prior to Globally-Coordinated Cessation of Bivalent Oral Poliovirus Vaccine (bOPV).Pathogens. 2024 Sep 17;13(9):804. doi: 10.3390/pathogens13090804. Pathogens. 2024. PMID: 39338995 Free PMC article.
-
Review of Poliovirus Transmission and Economic Modeling to Support Global Polio Eradication: 2020-2024.Pathogens. 2024 May 22;13(6):435. doi: 10.3390/pathogens13060435. Pathogens. 2024. PMID: 38921733 Free PMC article. Review.
-
Modeling the spread of circulating vaccine-derived poliovirus type 2 outbreaks and interventions: A case study of Nigeria.Vaccine X. 2024 Mar 16;18:100476. doi: 10.1016/j.jvacx.2024.100476. eCollection 2024 Jun. Vaccine X. 2024. PMID: 38617838 Free PMC article.
-
Trade-offs of different poliovirus vaccine options for outbreak response in the United States and other countries that only use inactivated poliovirus vaccine (IPV) in routine immunization.Vaccine. 2024 Feb 6;42(4):819-827. doi: 10.1016/j.vaccine.2023.12.081. Epub 2024 Jan 12. Vaccine. 2024. PMID: 38218668 Free PMC article. Review.
-
From vaccine to pathogen: Modeling Sabin 2 vaccine virus reversion and evolutionary epidemiology in Matlab, Bangladesh.Virus Evol. 2023 Jul 8;9(2):vead044. doi: 10.1093/ve/vead044. eCollection 2023. Virus Evol. 2023. PMID: 37692896 Free PMC article.
References
-
- Thompson KM. The role of risk analysis in polio eradication: modeling possibilities, probabilities and outcomes to inform choices. Expert Rev Vaccines. 2012;11(1):5–7. - PubMed
-
- Thompson KM, Duintjer Tebbens RJ, Pallansch MA, et al. Polio eradicators use integrated analytical models to make better decisions. Interfaces. 2015;45(1):5–25.
-
•• Gives an introduction of the complexities of polio and an overview of the contributions of Kid Risk, Inc modeling to GPEI decisions through 2014.
-
- Kid Risk, Inc. Kid Risk, Inc. publications - polio. 2020. [cited 2020 January10]; Available from: https://kidrisk.org/research/publications_Polio.html.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials